TOMMY-HILFIGER
31.8.2020 08:02:04 CEST | Business Wire | Press release
Tommy Hilfiger, which is owned by PVH Corp. [NYSE:PVH] announces Make it Possible, a bold approach to environmental and social sustainability that reinforces the organization’s commitment to create fashion that ‘Wastes Nothing and Welcomes All’. With Make it Possible, Tommy Hilfiger is initially committing to 24 ambitious targets centered around circularity and inclusivity, outlined across four pillars towards 2030:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200830005002/en/
- Circle Round: Make products to be fully circular, and part of a sustainable loop.
- Made for Life: Operate with sensitivity to planetary boundaries, for instance in the areas of climate change, land use, freshwater and chemical pollution, from what we buy to where we sell.
- Everyone Welcome: Be a brand that works for every TOMMY Fan – always inclusive, completely accessible.
- Opportunity for All: Create equal access to opportunity – no barriers to success at Tommy Hilfiger.
Tommy Hilfiger’s program is powered by parent company PVH Corp’s Forward Fashion strategy, a set of 15 priorities designed to reduce negative impacts to zero, increase positive impacts to 100%, and improve the over 1 million lives across the company’s value chain.
“I opened my first store, People’s Place, in 1969 in my hometown of Elmira for people of all backgrounds to come together and share exciting pop culture experiences,” said Tommy Hilfiger. “As our brand has evolved over the years, driven by this inclusive spirit, so has our commitment to social and environmental sustainability. With Make it Possible, we will go even further with our commitment. We’re working towards our vision with the entire organization focused on it and, while we’re not there yet, we are going to get there.”
“In these times of health, human, environmental and economic crisis, we share a responsibility to find innovative solutions that will encourage inclusivity and build a more circular future,” said Martijn Hagman, CEO, Tommy Hilfiger Global and PVH Europe. “It is in our nature to drive change, even in the most challenging of times, which is why we are announcing our ambitious Make it Possible sustainability program, outlining 24 targets towards 2030. Tommy Hilfiger has a decade’s long track-record for driving a more sustainable future, including pioneering low impact denim processes, championing water stewardship, and creating more inclusive collections. Make it Possible is one way we will work together to make a meaningful and lasting contribution towards a better fashion industry.”
Make it Possible marks the latest milestone in Tommy Hilfiger’s sustainability journey. Key achievements include the launch of Tommy Hilfiger Adaptive , designed to make dressing easier for adults and children with disabilities, and the Tommy Hilfiger Fashion Frontier Challenge , a global program aimed to support start-up and scale-up stage businesses developing solutions that promote inclusivity and sustainability in fashion. More recently Tommy Hilfiger launched People’s Place Program to advance the representation of black, indigenous and people of color (BIPOC) communities within the fashion and creative industries. To date, more than 80% of Tommy Hilfiger designers have been trained on circular design strategies and, in 2019, 72% of cotton used globally came from more sustainable sources. Additionally 2 million pieces of denim have been finished in lower impact, reducing the amount of water and energy used. Each seasonal TOMMY HILFIGER collection includes more sustainable styles in its collections, as evidenced by the 50% more sustainable styles planned for Spring 2021, double the amount from Spring 2020.
Recognizing that no one company can change the sustainability landscape alone, Tommy Hilfiger, as part of PVH Corp., has joined forces with industry partners by signing The Fashion Pact in August 2019, as well as joining the Ellen MacArthur Foundation Make Fashion Circular and Jeans Redesign initiatives. For the past several years, Tommy Hilfiger has partnered with the WWF to address water risk in our strategic supply chain locations. This includes training on water risk management for suppliers and industrial parks in China’s Taihu River Basin and serving as the founding brand partner of a new water stewardship program in Vietnam in the Mekong basin.
Throughout its journey, Tommy Hilfiger will share its progress. For more information on Make it Possible and a full overview of achievements to date, visit: http://sustainability.tommy.com .
About Tommy Hilfiger
With a brand portfolio that includes TOMMY HILFIGER
and TOMMY JEANS
, Tommy Hilfiger is one of the world’s most recognized premium designer lifestyle groups. Its focus is designing and marketing high-quality men’s tailored clothing and sportswear, women’s collection apparel and sportswear, kidswear, denim collections, underwear (including robes, sleepwear and loungewear), footwear and accessories. Through select licensees, Tommy Hilfiger offers complementary lifestyle products such as eyewear, watches, fragrance, swimwear, socks, small leather goods, home goods and luggage. The TOMMY JEANS
product line consists of jeanswear and footwear for men and women, accessories, and fragrance. Merchandise under the TOMMY HILFIGER
and TOMMY JEANS
brands is available to consumers worldwide through an extensive network of TOMMY HILFIGER
and TOMMY JEANS
retail stores, leading specialty and department stores, select online retailers, and at tommy
.com
.
About PVH Corp.
PVH is one of the most admired fashion and lifestyle companies in the world. We power brands that drive fashion forward – for good. Our brand portfolio includes the iconic CALVIN KLEIN
, TOMMY HILFIGER
, Van Heusen
, IZOD
, ARROW, Warner’s
, Olga
and Geoffrey Beene
brands, as well as the digital-centric True&Co.
intimates brand. We market a variety of goods under these and other nationally and internationally known owned and licensed brands. PVH has over 40,000 associates operating in over 40 countries and $9.9 billion in annual revenues. That's the Power of Us. That’s the Power of PVH.
Follow us on Facebook , Instagram , Twitter and LinkedIn .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200830005002/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
